The rising trend of nicotine pouches, now a popular alternative to tobacco use, is triggering significant public health worries. A nicotine pouch is a smokeless product introduced by the tobacco industry, often misleading users into thinking they are harmless despite containing high nicotine levels. Health professionals are urged to update their screening practices to include nicotine pouch use. Although cigarette smoking among U.S. high school students dropped from 36.4% in 1997 to 1.7% in 2024, the industry continues to innovate, particularly targeting youth with nicotine pouches.
Nicotine Pouch FDA Approval and Health Risks
Nicotine pouches were approved by the FDA in January 2025 and are marketed as a convenient, flavorful nicotine source. Despite approval, these products pose health risks. Experts like Joanna Cohen from Johns Hopkins Bloomberg School of Public Health call for stricter regulation and awareness, as the tobacco industry often bypasses advertising restrictions to promote new products.
Industry Adaptation and Youth Appeal
The shift from traditional smoking to vaping and now nicotine pouches shows the tobacco industry’s adaptability. Vaping gained popularity among youth until regulations curtailed its use (vaping use remains high and poses risks, especially for young users). Now, similar marketing strategies make nicotine pouches appealing to younger people.
Nicotine Levels and Health Implications
Research, including a BMJ Tobacco Control journal study, indicates nicotine pouches contain carcinogenic chemicals. Some pouches have nicotine levels up to 50 mg, compared to 8 to 20 mg in cigarettes, heightening addiction risk and health issues like increased blood pressure and heart rate.
Labeling and Consumer Awareness
Johannes Thrul from Johns Hopkins highlights labeling issues, with 29 out of 44 products lacking clear nicotine content disclosure, complicating consumer awareness. Many users report adverse effects, with 97% experiencing negative outcomes like sore throats and mouth lesions.
Healthcare Provider Role
Physicians like Daron W. Gersch stress the need for expanded nicotine use screening in consultations. Many users underestimate the harm of nicotine pouches and may not disclose usage unless specifically asked.
Advocacy and Education
To counteract nicotine pouch use, healthcare professionals should engage patients in discussions about nicotine use and provide cessation resources. The American Academy of Family Physicians offers tools to help primary care providers support patients in quitting nicotine.
Foundry Front Range Perspective
At Foundry Front Range, we emphasize comprehensive behavioral healthcare to address substance use and mental health disorders. We advocate against the commercialization of substances like nicotine due to their health risks, including substance use disorder. To give clients a better chance at recovery and to protect the health of team members, Foundry Front Range is a tobacco-free environment. Nicotine can be a substance of abuse. When people are learning to abstain from the use of mind-altering chemicals, they can sometimes turn to nicotine as a crutch because it is perceived as less dangerous than alcohol, drugs, and other substances. However, nicotine use is not only a health risk. However, leaning on nicotine use during addiction treatment can counteract the notion that people can overcome the compulsive urge to use chemicals to feel normal or to address underlying health conditions.
Het Help for Nicotine Addiction
If you or a loved one needs help stopping their use of nicotine, many resources are available. Nicotine cessation is an important step toward overall health and wellness. Treatment, counseling, and medications are available to help people stop using nicotine products. Foundry Front Range treats many forms of substance use disorder, and many of our clients experience problematic nicotine use, among other substance use disorders. Contact us to learn more.
Click here to see a source article for this post and learn more.
Podcast transcript:
Welcome to another episode of Foundry Front Range Behavioral Health Insights. Today, we delve into a concerning trend that’s gaining momentum among youth: the use of nicotine pouches. These smokeless tobacco alternatives are marketed as convenient and flavorful, but behind the glossy facade lurks a significant public health challenge.
Recent FDA approval of nicotine pouches has sparked debate. While they are presented as a safer alternative to smoking, these products contain alarmingly high nicotine levels, sometimes reaching up to 50 mg. This is a stark contrast to the 8 to 20 mg typically found in cigarettes. Such high concentrations increase the risk of addiction and can lead to health issues like elevated blood pressure and heart rate.
The tobacco industry is no stranger to adaptation. As cigarette use among high schoolers plummeted from 36.4% in 1997 to 1.7% in 2024, the industry shifted its focus. It moved from cigarettes to vaping, and now, to nicotine pouches. This evolution showcases the industry’s resilience and its relentless targeting of younger audiences. Clever marketing strategies have made these nicotine pouches appealing, but the health implications are a growing concern.
Research indicates that these pouches are not devoid of risks. In fact, the BMJ Tobacco Control journal highlights the presence of carcinogenic chemicals in these products. Moreover, a significant lack of transparency regarding nicotine content further complicates users’ ability to make informed choices. Johannes Thrul from Johns Hopkins reveals that a staggering 29 out of 44 products fail to clearly disclose nicotine content, leaving consumers in the dark about what they’re truly consuming.
Healthcare professionals play a crucial role in addressing this issue. Physicians like Daron W. Gersch emphasize the importance of expanding nicotine use screening to include these new products. Often, users underestimate the harm of nicotine pouches and may not disclose their usage unless specifically asked. This calls for a proactive approach in healthcare consultations, engaging patients in discussions about nicotine use and offering support and resources for cessation.
At Foundry Front Range, we believe in comprehensive behavioral healthcare that tackles both substance use and mental health disorders. Nicotine addiction’s complexities demand robust public health strategies and transparency in product labeling. By fostering open conversations and providing cessation resources, we can enhance health outcomes for individuals and communities.
Our stance is clear: we advocate against the commercialization of substances like nicotine, which pose significant health risks. It’s essential to dismantle misleading safety narratives and promote holistic treatment approaches that consider all aspects of a person’s health. Supporting long-term recovery and well-being is at the core of our mission, and we remain committed to this cause.
